Skip to main content

Recombinant Human IL-21 Protein, CF Best Seller

R&D Systems, part of Bio-Techne | Catalog # BT-021

Analyzed by SEC-MALS
R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
BT-021-010
BT-021-01M
BT-021-050
BT-021-100
BT-021-250
BT-021-500

Key Product Details

  • R&D Systems E. coli-derived Recombinant Human IL-21 Protein (BT-021)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession #

Conjugate

Unconjugated

Applications

Bioactivity

Product Specifications

Source

E. coli-derived human IL-21 protein
Gln32-Ser162 with a N-terminal Met

Purity

>95%, by SDS-PAGE with quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met

Predicted Molecular Mass

15 kDa

SDS-PAGE

15-17 kDa, under reducing conditions.

Activity

Measured in a cell proliferation assay using B9 mouse hybridoma cells.
The ED50 for this effect is 5.00-50.0 ng/mL.

Scientific Data Images for Recombinant Human IL-21 Protein, CF

Recombinant Human IL‑21 Protein SEC-MALS.

Recombinant Human IL‑21 (Catalog # BT-021) has a molecular weight (MW) of 17.9 kDa as analyzed by SEC-MALS, suggesting that this protein is a monomer.

Recombinant Human IL‑21 Protein Bioactivity.

Recombinant Human IL-21 induces cell proliferation of B9 mouse hybridoma cells with an ED50 of 5.00-50.0 ng/mL.

Recombinant Human IL‑21 Protein SDS-PAGE.

2 μg/lane of Recombinant Human IL‑21 Protein (Catalog # BT-021) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 15-17 kDa, under reducing conditions.

Formulation, Preparation and Storage

BT-021
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details.
Reconstitution Reconstitute the 10 μg size at 100 μg/mL in PBS. Reconstitute all other sizes at 500 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: IL-21

IL-21 (Interleukin-21) is member of the family of cytokines that utilize the common gamma chain as a receptor subunit. This subunit is also a component of the receptors for IL-2, IL-4, IL-7, IL-9, and IL-15. IL-21 is produced by activated T follicular helper cells (Tfh), Th17 cells, and NKT cells. It exerts its biological effects through a heterodimeric receptor complex of the common gamma chain and the IL-21-specific IL-21 R. IL-21 supports Tfh cell development, immunoglobulin affinity maturation, plasma cell differentiation, B cell memory responses, and the migration of dendritic cells to draining lymph nodes. It costimulates the activation, proliferation, and survival of CD8+ T cells and NKT cells and promotes Th17 cell polarization. It blocks the generation of regulatory T cells and their suppressive effects on CD4+ T cells. In addition, IL-21 suppresses cutaneous hypersensitivity reactions by limiting allergen-specific IgE production and mast cell degranulation.

Long Name

Interleukin 21

Alternate Names

CVID11, IL21, Za11

Entrez Gene IDs

59067 (Human); 60505 (Mouse); 365769 (Rat); 442935 (Canine); 100344172 (Rabbit)

Gene Symbol

IL21

UniProt

Additional IL-21 Products

Product Documents for Recombinant Human IL-21 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human IL-21 Protein, CF

For research use only

Loading...
Loading...
Loading...